Moreover, using a reporter assay and a ChIP assay, our study demonstrates that Notch3 is capable of binding to CSL-binding motifs in the promoter of GATA-3 in breast cancer cells, suggesting that N3ICD directly activates GATA-3 expression. Here, RBPJ is linked to breast cancer.